eCARTv5 Clinical Deterioration Suite (eCART) vs Elsevier

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

eCARTv5 Clinical Deterioration Suite (eCART)

by AgileMD

Elsevier

by Elsevier

AI Verdict

While both tools offer AI-powered clinical decision support, AgileMD's eCARTv5 focuses on continuous patient risk assessment and prediction of clinical deterioration, integrating directly into EHRs to guide care with embedded pathways. Elsevier's ClinicalKey AI, conversely, is primarily an evidence-based medical information retrieval system, providing rapid access to journals, books, and practice guidelines to support diagnostic and treatment decisions. Therefore, eCARTv5 is suited for proactive patient monitoring and early intervention, whereas ClinicalKey AI is for comprehensive information lookup and learning.

Choose eCARTv5 Clinical Deterioration Suite (eCART) if…

Choose eCARTv5 Clinical Deterioration Suite if your hospital needs an AI-powered, FDA-cleared solution for continuous, real-time prediction of clinical deterioration in hospitalized adult patients. This tool excels at integrating with EHRs to provide early warnings (hours before critical illness) and guide care with embedded clinical pathways, minimizing false alarms and clinician workload. It is ideal for proactive risk assessment and intervention to prevent adverse outcomes like ICU transfer or death.

View eCARTv5 Clinical Deterioration Suite (eCART) →

Choose Elsevier if…

Choose Elsevier's ClinicalKey AI if individual clinicians or institutions require rapid access to evidence-based medical information and clinical decision support across a wide range of specialties. This tool leverages AI for conversational search, providing summarized clinical answers, access to full-text journals and books, practice guidelines, and drug information. It is best suited for enhancing diagnostic confidence, streamlining information retrieval, and supporting ongoing medical education and research.

View Elsevier →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	Elsevier
Pricing	Contact vendor for tailored quote.	Paid subscription, with individual and institutional plans.
Deployment	Cloud-based SaaS, integrated directly into Electronic Health Record (EHR) systems.	Cloud-based, with EHR integration (Epic, DrFirst iPrescribe) and API compatibility.
BAA Available	Unknown	Yes AI-estimated
FDA Status	1 AI-estimated	Unknown
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Elsevier

Elsevier's ClinicalKey AI offers a streamlined interface, intuitive navigation, and native voice-to-text dictation in its mobile app, enhancing usability at the bedside or on the go. It also includes features like query history management and the ability to share results, further improving the user experience. While AgileMD's eCARTv5 is noted for its intuitive interface and user-friendly design, specific features enhancing usability beyond general design are not as extensively detailed in the provided information.

Clinical Value

eCARTv5 Clinical Deterioration Suite (eCART)

AgileMD's eCARTv5 is an FDA-cleared Software as a Medical Device (SaMD) that continuously assesses and predicts the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients, providing early warnings hours before critical illness. It has undergone multicenter prospective validation, demonstrating superior performance in identifying clinical deterioration compared to other early warning scores. ClinicalKey AI, while providing evidence-based medical information and summarized clinical answers, functions more as a decision support tool for information retrieval rather than a predictive risk assessment tool for patient deterioration.

Pricing & Value

Elsevier

Elsevier's ClinicalKey AI offers transparent individual pricing plans at $39/month or $349/annually, with a 90-day free trial for clinicians and residents, and a one-year free trial for medical students. AgileMD's eCARTv5 requires contacting the vendor for a tailored quote, with no publicly listed pricing details, making its value proposition less transparent for initial assessment.

Enterprise Readiness

Tie

Both tools demonstrate strong enterprise readiness. AgileMD's eCARTv5 is designed for cloud-based SaaS deployment and integrates directly into EHR systems, with features like reporting and benchmarking capabilities. ClinicalKey AI also offers cloud-based deployment with EHR integration (Epic, DrFirst iPrescribe) and API compatibility, along with multi-language support and data export capabilities for institutional use. Both are HIPAA compliant and have BAA agreements.

Innovation

eCARTv5 Clinical Deterioration Suite (eCART)

AgileMD's eCARTv5 utilizes an AI-powered gradient-boosted machine-learning model for continuous, real-time prediction of clinical deterioration, offering an early warning system hours before critical illness. This proactive, predictive capability for patient outcomes represents a significant innovation in clinical decision support. ClinicalKey AI's innovation lies in its AI-powered conversational search and summarization of extensive medical literature, which is valuable but more focused on information access rather than predictive analytics for patient status.

Support & Docs

Tie

Both tools offer robust support. AgileMD provides 24/7 live support, email, phone, chat, FAQ, help desk, knowledge base, and training resources. Elsevier's ClinicalKey AI offers customer support and resources, including a privacy panel to manage query history and references linked to original sources for validation and deeper review. Without more specific comparative details on the depth and responsiveness of support, it's difficult to declare a definitive winner.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	eCARTv5 Clinical Deterioration Suite (eCART)	Elsevier
Name	eCARTv5 Clinical Deterioration Suite (u201ceCARTu201d)	Elsevier ClinicalKey AI
Company	AgileMD	Elsevier
Description	FDA-cleared, AI-powered Software as a Medical Device (SaMD) that integrates with EHRs to continuously assess and predict the risk of clinical deterioration (death or ICU transfer) in hospitalized adult patients, guiding care with embedded clinical pathways.	Clinical decision support tool that uses artificial intelligence to provide physicians with rapid access to evidence-based medical information.
Key Features	AI-powered clinical deterioration prediction, Continuous patient risk assessment (death or ICU transfer), EHR integration with real-time data (up to 97 variables), Embedded clinical pathways for care guidance, Early warning system (alerts hours before critical illness), Risk stratification (eCART score and risk designation), Minimizes false alarms and clinician workload, Reporting and benchmarking capabilities	AI-powered search, Evidence-based content, Summarized clinical answers, Access to journals and books, Practice guidelines, Drug information, Multimedia resources, Personalized content recommendations
Free Trial	Not specified	yes, clinicalkey ai offers a 90-day free trial for clinicians and residents, and a 14-day free trial for clinicalkey essentials. medical students in the US and Canada get one year free for clinicalkey ai.
Mobile App	Not specified	Yes, ClinicalKey has a mobile app available for Android and iOS devices, which includes native voice-to-text dictation for ClinicalKey AI.

Videos

Demos, reviews, and walkthroughs featuring eCARTv5 Clinical Deterioration Suite (eCART) and Elsevier.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

How do these tools integrate into a physician's existing workflow and EHR system?

eCARTv5 is designed for continuous patient risk assessment, integrating directly into EHRs to provide real-time data and embedded clinical pathways for care guidance. ClinicalKey AI, while also cloud-based with EHR integration (Epic, DrFirst iPrescribe) and API compatibility, functions more as a conversational search and reference tool on top of a vast content library, meaning a physician would typically stop their current task to query the system and then return to the EHR.

What is the accuracy and sensitivity of each tool in its respective function?

eCARTv5 uses a gradient-boosted machine learning model, trained on a multi-center dataset of over 800,000 patient records and 97 variables, to predict clinical deterioration (death or ICU transfer) with high accuracy, outperforming other early warning scores. ClinicalKey AI focuses on providing evidence-based answers to clinical questions, with real-time citation validation checks to ensure responses are grounded in evidence and a clinician-in-the-loop framework to assess for accuracy and bias.

For which medical specialties are these tools most suitable?

eCARTv5 is primarily designed for critical care, emergency medicine, and hospital medicine, focusing on identifying and managing clinical deterioration in hospitalized adult patients. ClinicalKey AI supports a much broader range of specialties, including cardiology, dermatology, emergency medicine, internal medicine, oncology, pediatrics, and many others, by providing comprehensive evidence-based medical information.

What is the learning curve for physicians to effectively use each tool?

eCARTv5 integrates into the EHR with embedded clinical pathways, suggesting a learning curve focused on understanding and acting upon its risk scores and guidance within existing workflows. ClinicalKey AI offers a streamlined navigation and intuitive interface with natural language querying, and a mobile app with voice-to-text dictation, aiming for ease of use in accessing information quickly.